Introduction
As of 2014, more than two million Canadians have a diagnosis of diabetes, according to the Public Health Agency of Canada.
Approximately, 1 in 17 Canadians are afflicted with the disease-5.5 per cent of all women in the country and 6.2 per cent of all men. It is estimated another five million -15 per cent of the country's population -are pre-diabetic. Among older Canadians (aged 75 to 79), 22 per cent have been diagnosed with diabetes. The CNIB reports blindness due to diabetes as the leading cause of vision loss in Canadians under the age of 50. These figures are cause for great alarm.
Types of Diabetes
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Type 1 Diabetes
Type 1 Diabetes, formerly called juvenile diabetes or insulin-dependent diabetes, is usually first observed in children, teenagers or adults under the age of thirty and is the result of the body producing little or no insulin. Type 1 diabetes is primarily controlled by insulin injections so it is often referred to as insulin dependent diabetes.
Type 2 Diabetes
Type 2 diabetes or adult on-set diabetes is the most common form of diabetes. In this type of diabetes the body does produce some insulin, but the amount is either not sufficient or the body is not able to make proper use of it. Type 2 diabetes is generally controlled by a combination of diet, exercise and/or medication.
Nearly all patients with Type 1 diabetes and 60 per cent of those with Type 2 will develop some form of diabetic retinopathy within the first 20 years of living with the disease. In addition to vision loss, people who have diabetes have a higher risk for heart disease, hypertension, stroke, kidney disease, neuropathy, gum disease and difficult to treat skin conditions. Ocular complications affecting vision caused by diabetes are cataracts, glaucoma and diabetic retinopathy.
Diabetic Eye Disease Overview
Diabetes can have devastating ocular implications, including blindness. Diabetic retinopathy is a progressive disease that destroys capillaries which link arteries to veins in the eye by depositing an abnormal material along the walls of the tiny blood vessels in the retina. It is the most serious ocular complication caused by diabetes.
Forty per cent of people with Type 1 diabetes and 20 per cent with Type 2 will develop some sort of retinopathy.
First Nations citizens and those with diabetes are 25 times more likely to experience vision loss and blindness than other populations. Dr. Paul Chris, Executive Director of the Vision Institute of Canada stated in an issue of the Canadian Journal of Optometry "with the disproportionate and increasing number of native people with diabetes, and its occurrence at a much earlier age than the general population, diabetes will lead to a more significant burden of preventable vision loss in Aboriginal communities than in non-Aboriginal groups."
Fluctuating Vision
Patients afflicted with undiagnosed diabetes often present with complaints of fluctuating vision, often at various times during the day. They may also report, with a certain amount of doubt, they no longer need their glasses to see in the distance. This is due to the swelling of the crystalline lens and/or corneal tissues, secondary to elevated and unstable blood sugar (glucose) levels. Any patient presenting with these symptoms should be referred to their general practitioner for a full evaluation.
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The blurred, fluctuating vision that continues to plague the patient once treatment is initiated is almost never caused by changes in the retina. It is a result of the speed at which the swelling, due to previously high blood glucose levels, dissipate from the crystalline lens and/or corneal tissue. These continuing visual changes rarely indicate retinal damage unless uncontrolled high blood glucose levels have been present for at least five years.
As an eye care professional, when taking a patient history or speaking with your patients in general, it is important that you discuss with your diabetic patients the possible ocular complications associated with the disease. Diabetic retinopathy has few visual or ophthalmic symptoms until vision loss develops. Because the treatments discussed in this article are aimed at preventing vision loss, it is important for patients to be treated early in the disease. To achieve this goal, patients with diabetes should be advised to have annual dilated eye examinations to detect and track this treatable disease.
Non-proliferative Retinopathy/Background
Non-proliferative retinopathy, also known as background retinopathy, is the result of two major processes affecting the retinal blood vessels:
• abnormal vessel permeability
Abnormal Retinal Vessel Permeability
Retinal blood vessels are different from vessels elsewhere in the body. Most blood vessels have small fenestrations. These openings are small enough to allow fluid to pass through the vessel wall along with larger blood elements such as blood cells and large proteins to have an outlet; however, they are large enough to allow water and small molecules such as ions to pass. The difference is that retinal blood vessels have tight junctions between the cells of the blood vessel wall. This causes all fluid and molecules exiting the vessel to pass through the cells. The lack of fenestration helps the retina to maintain relative dehydration, which is necessary for proper function.
In retinopathy, the vessels become more permeable. Water, blood cells, proteins, fats, and other large molecules may leak out into the surrounding retinal tissue. Accumulation of this fluid in the macula region causes macular edema or diabetic maculopathy, which is described later in this article.
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Micro Aneurysms
Retinal Vessel Closure
Early vessel closures in non-proliferative retinopathy are usually in the capillaries. These small vessels are critical to the health of the retina, since they are needed to deliver oxygen and nutrients to the area and to carry away carbon dioxide and other waste products.
Capillary closure causes areas of decreased oxygen supply to the small patches of retina which correspond to these capillaries. There is an associated dilation of the adjacent capillaries. This can result in small dilations of the capillaries referred to as micro aneurysms. These are small sacs which protrude from the vessel. These are often visible on the retina as tiny red dots on dilated examination.
Diabetic Maculopathy
This condition is the most common cause of decreased vision in patients with non-proliferative diabetic retinopathy. On examination it is seen as a thickening, slightly gray coloration in the retina. This is often associated with exudates which are yellow clumps or spots within the retina. Exudates are the result of fats and proteins leaking out of the permeable vessels along with water. The water can be quickly reabsorbed into vessels or into the tissue under the retina, but the fatty material is absorbed very slowly.
Exudates in Diabetic Maculopathy
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When the laser light hits blood or pigment, it is absorbed as heat energy which produces a small burn which creates a faint scar under the retina (This is similar to treatment for ARMD). This is usually is not noticed by the patient. It takes about a month for the edema to decrease and for the patient's vision to improve.
Proliferative Diabetic Retinopathy (PDR)
In proliferative diabetic retinopathy, the most severe stage of diabetic eye disease, new blood vessels proliferate on the surface of the retina. Most patients with PDR have had non-proliferative retinopathy for a few years prior to developing the proliferative form of the disease. PDR is diagnosed when new proliferating blood vessels (neovascularization) form in the retina or optic disc and grow on the retinal surface or into the vitreous cavity. This diagnosis is made by examination of the retina and sometimes by fluorescein angiography. In this test, a special dye is injected into a vein in the patient's arm. As the dye passes through the blood vessels in the retina, photographs are taken by a trained ophthalmic technician/photographer. The test allows the ophthalmologist to see areas of leaking vessels and to determine the best treatment method.
New Vessel Growth in Proliferative Retinopathy
The photograph above shows a clump of neovascularization which extends from the optic nerve head and into the vitreous cavity. These new vessels take on a frond-like appearance as they grow.
Neovascularization in PDR is most likely caused by ischemia (decreased blood supply) of the retina. In diabetes, multiple small patches of the retina lose blood supply because of closure of retinal capillaries. When areas of the retina are deprived
Over time, the tiny, fine new vessels gradually become larger and more mature. Eventually, the newer vessels tend to regress, leaving behind the scar tissue and larger, more mature vessels.
Treatment of Proliferative Retinopathy
When only very small areas of new vessels develop, the patient can be watched closely without treatment, since the new vessels may not continue to grow. Patients with more extensive new vessel growth usually undergo a laser treatment called pan retinal photocoagulation (PRP).This involves extensive treatment with an argon or diode laser to the peripheral and mid portions of the retina. The central or macular region cannot be treated, since this would cause serious vision loss. Pan retinal photocoagulation is usually an in-office procedure performed without anesthesia. The initial treatment usually consists of approximately 1,000 to 1,500 spots of laser per eye. This is most often done in several sessions. The patient's vision is usually poor immediately after the treatment, but returns to the pre-treatment level within a few hours.
Complications of Proliferative Diabetic Retinopathy Vitreous Hemorrhage
New vessels tend to be very fragile and may bleed, filling the vitreous chamber with blood. When vitreous hemorrhages occur, patients notice black or red strings or cobweb-like effects in the vision. As the blood disperses through the vitreous cavity, the vision becomes blurred or dim. Vision is significantly impaired if a great deal of bleeding occurs.
The eye is able to clean blood out of the vitreous cavity as long as there is not too much blood. Some of the red blood cells diffuse forward into the anterior portion of the eye and are removed by flowing through the trabecular meshwork, as does aqueous humor. White blood cells also move into the vitreous, ingest the old red blood cells, and carry them away.
Unfortunately, these processes are very slow. A small amount of blood in the vitreous can sometimes be removed in this manner in a few weeks, whereas larger hemorrhages may take months or years to clear. In cases of dense blood or multiple recurrent hemorrhages, the vision may not return because of residual inflammatory debris and dead cells that cannot be removed. Vitreous hemorrhage is a concern not only because of the poor vision, but also because of the poor visibility into the eye making retinal examination difficult or impossible.
| P a g e
Vitreous Hemorrhage
Treatment of Vitreous Hemorrhage
A surgical procedure known as a vitrectomy can be performed to remove blood and debris from the vitreous cavity. When a vitrectomy is performed, three incisions, approximately 1 mm each, are made into the eye. Through one of these incisions, an infusion cannula-much like a small tube-is inserted and sutured into place. This allows a continuous infusion of saline solution to keep the eye inflated at the proper intraocular pressure. A fiber optic light source is inserted through one incision, and a suction/cutter device through another. The suction/cutter has a small port with a rotating or sliding blade inside. Vitreous gel and blood are sucked into the port, cut off by the blade and removed from the eye. The surgeon watches through a contact lens that is placed on the cornea while looking through a microscope. After the blood and vitreous are removed, any additional treatment needed can be performed, including laser treatment, cautery of bleeding sites or removal of scar tissue.
Risks and complications of vitrectomy:
• 5% risk of retinal tears or detachments caused by the procedure itself
• 10%-40% risk of visually significant cataract in patients who have not previously undergone cataract surgery.
• 20-30% risk of recurrent bleeding in the eye in the first few days following the surgery. This often clears more quickly than the initial hemorrhage and usually does not require further surgery, but the return of vision is slow.
A vitrectomy is performed only when the potential risks are outweighed by the expected benefits. Despite the inconvenience of decreased vision for several months, patients are often better off waiting for the blood to clear on its own if a hemorrhage is relatively mild. If the blood has not cleared spontaneously in 4-6 months, or if waiting would be dangerous due to retinal detachment or untreated neovascularization, surgery is indicated earlier.
Traction Retinal Detachment
One of the most serious complications of diabetic eye disease is traction retinal detachment. As previously mentioned, the new vessels tend to develop scar tissue. Like any scar, this tissue contracts or shrinks as it matures. If the neovascularization is on the surface of the retina, the contraction of the scar may produce some distortion of the retina. Vessels that grow out into the vitreous cavity develop adhesions within the contents of the vitreous gel. In some cases, vitrectomy, as discussed above, is the most advantageous surgical intervention, but only if a retinal break has not occurred.
It is a normal change in aging for the vitreous to separate away from the retina, particularly if the gel is abnormally adherent to the retina or the retina is weak in a certain area. The vitreous may pull away from the retina to such an extent as to cause a posterior retinal detachment. That process combined with scar tissue pulling on the retina produces traction that can distort and/or cause what is referred to as a traction retinal detachment. The liquid vitreous passes through the break and goes under the retina. The retina will then start to detach from the underlying tissue. Since most tears occur in the peripheral retina, the detachment will first cause loss of a portion of the peripheral vision. This can be seen as a curtain or dark shadow involving the peripheral vision. As the detachment extends towards the macula, the shadow will enlarge.
While some traction detachments can be minimal and have little effect on the vision, without surgical repair many traction detachments will eventually involve the entire retina. Central vision will be lost if the macula detaches.
Traction Detachment Before and After Surgery
Additional Surgical Intervention for Retinal Detachment Scleral Buckle
This procedure is performed for detachments associated with a hole, break or tear in the sensory layer known as rhegmatogenous retinal detachments. Scleral buckling involves localizing and freezing tissues with a cryoprobe (cryopexy) and reinforcing all the retinal breaks. The buckle is usually a piece of silicone sponge or solid silicone. The type and shape of the buckle varies depending on the location and number of retinal breaks. The buckle is sewn onto the sclera to create an indentation or buckle effect inside the eye. The buckle is positioned so that it pushes in on the break and closes the break.
Once the break is closed, the sub-retinal fluid will usually spontaneously resolve over a day or two. Sometimes the fluid is drained during the surgery. The surgery is usually done as an outpatient hospital procedure using local anesthesia.
Pneumatic Retinopexy
This procedure has been used only in the past ten years. It is a way to repair rhegmatogenous retinal detachment, particularly if there is a single break or tear located in the superior portion of the retina. A gas bubble is injected into the 9 | P a g e vitreous cavity. If the break can be covered by the bubble, the sub-retinal fluid will usually resolve within a couple of days.
The retinal tear is either treated with cryopexy before the bubble is injected or with laser after the retina has flattened. This type of surgery can be done in the office and it avoids some of the complications of scleral buckling surgery. Precise positioning of the patient's head for up to 10 days following the procedure is essential. This is a major disadvantage. This procedure has a slightly lower success rate than the scleral buckle. If the retina does not reattach a buckle can be done. has not yet received FDA approval.
What the Future May Hold
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Post Test: Diabetes and Ocular Complications
Complete the following quiz based on the above information and submit the quiz via email, fax, or mail to the ACAO to receive 2EC credits. Note: More than one answer may apply 
